Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 1/2014

01-02-2014 | Commentary

Challenges in measuring medication adherence: experiences from a controlled trial

Authors: Kay Stewart, Kevin P. Mc Namara, Johnson George

Published in: International Journal of Clinical Pharmacy | Issue 1/2014

Login to get access

Abstract

Measurement of adherence is complex and many methods, both direct and indirect are used; there is no universal gold standard. In this article, we share our experiences in a randomised controlled study, the Hypertension Adherence Program in Pharmacy trial, evaluating a community pharmacy-based intervention for improving adherence to antihypertensive medication. Several objective and subjective measures of adherence (Morisky score, TABS score, MedsIndex, Medicines Possession Ratio) were used, but produced varying results, limiting confidence in the conclusions that could be drawn. Despite using a specifically designed data mining software program to identify potentially nonadherent patients from dispensing records, many participants were found to be adherent by the self reported Morisky scale. A lesson to be learned when targeting people for interventions to improve adherence is that information from dispensing records should be supplemented by other methods in order to identify patients most in need of assistance.
Literature
2.
go back to reference Farmer K. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21(6):1074–90.PubMedCrossRef Farmer K. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21(6):1074–90.PubMedCrossRef
3.
go back to reference Lau R, Stewart K, Mc Namara K, Jackson SL, Hughes JD, Peterson GM, et al. Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomized controlled trial. BMC Health Serv Res. 2010;10(1):34.PubMedCentralPubMedCrossRef Lau R, Stewart K, Mc Namara K, Jackson SL, Hughes JD, Peterson GM, et al. Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomized controlled trial. BMC Health Serv Res. 2010;10(1):34.PubMedCentralPubMedCrossRef
4.
go back to reference Nelson MR, Reid CM, Ryan P, Willson K, Yelland L. Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2). MJA. 2006;185(9):487–9.PubMed Nelson MR, Reid CM, Ryan P, Willson K, Yelland L. Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2). MJA. 2006;185(9):487–9.PubMed
5.
go back to reference Bramley TJ, Gerbino PP, Nightengale BS, Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm. 2006;12(3):239–45.PubMed Bramley TJ, Gerbino PP, Nightengale BS, Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm. 2006;12(3):239–45.PubMed
6.
go back to reference Ho PM, Magid DJ, Masoudi FA, McClure DL, Rumsfeld JS. Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease. BMC Cardiovasc Disord. 2008;6:48. doi:10.1186/1471-2261-6-48.CrossRef Ho PM, Magid DJ, Masoudi FA, McClure DL, Rumsfeld JS. Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease. BMC Cardiovasc Disord. 2008;6:48. doi:10.​1186/​1471-2261-6-48.CrossRef
8.
go back to reference Chapman RH, Benner JS, Petrilla AA, Tierce JC, Collins SR, Battleman DS, et al. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med. 2005;165(10):1147–52.PubMedCrossRef Chapman RH, Benner JS, Petrilla AA, Tierce JC, Collins SR, Battleman DS, et al. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med. 2005;165(10):1147–52.PubMedCrossRef
9.
go back to reference Vrijens B, Vincze G, Kristant P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ. 2008;336:1114–7.PubMedCrossRef Vrijens B, Vincze G, Kristant P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ. 2008;336:1114–7.PubMedCrossRef
10.
go back to reference Simons LA, Ortiz M, Calcino G. Persistence with antihypertensive medication: Australia-wide experience, 2004–2006. MJA. 2008;188(4):224–7.PubMed Simons LA, Ortiz M, Calcino G. Persistence with antihypertensive medication: Australia-wide experience, 2004–2006. MJA. 2008;188(4):224–7.PubMed
11.
go back to reference Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44–7.PubMedCrossRef Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44–7.PubMedCrossRef
12.
go back to reference Briganti EM, Shaw JE, Chadban SJ, Zimmet PZ, Welborn TA, Mcneil JJ, Atkins RC. Untreated hypertension among Australian adults: the 1999–2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). MJA. 2003;179(3):135–9.PubMed Briganti EM, Shaw JE, Chadban SJ, Zimmet PZ, Welborn TA, Mcneil JJ, Atkins RC. Untreated hypertension among Australian adults: the 1999–2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). MJA. 2003;179(3):135–9.PubMed
13.
go back to reference Janus ED, Bubker SJ, Kilkkinen A, Mc Namara KM, Philpot B, Tideman P, et al. Prevalence, detection and drug treatment of hypertension in a rural Australian population: the Greater Green Triangle Risk Factor Study 2004-2006. Intern Med J. 2008;38:879–86.PubMedCrossRef Janus ED, Bubker SJ, Kilkkinen A, Mc Namara KM, Philpot B, Tideman P, et al. Prevalence, detection and drug treatment of hypertension in a rural Australian population: the Greater Green Triangle Risk Factor Study 2004-2006. Intern Med J. 2008;38:879–86.PubMedCrossRef
14.
go back to reference Brown MJ, Cruickshank JK, Dominiczak AF, MacGregor GA, Poulter NR, Russell GI, et al. Better blood pressure control: how to combine drugs. J Hum Hypertens. 2003;17(2):81–6.PubMedCrossRef Brown MJ, Cruickshank JK, Dominiczak AF, MacGregor GA, Poulter NR, Russell GI, et al. Better blood pressure control: how to combine drugs. J Hum Hypertens. 2003;17(2):81–6.PubMedCrossRef
15.
go back to reference Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens. 2006;19(11):1190–6.PubMedCrossRef Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens. 2006;19(11):1190–6.PubMedCrossRef
16.
go back to reference Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74.PubMedCrossRef Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74.PubMedCrossRef
17.
go back to reference George J, Mackinnon A, Kong DC, Stewart K. Development and validation of the beliefs and behaviour questionnaire (BBQ). Patient Educ Couns. 2006;64:50–60.PubMedCrossRef George J, Mackinnon A, Kong DC, Stewart K. Development and validation of the beliefs and behaviour questionnaire (BBQ). Patient Educ Couns. 2006;64:50–60.PubMedCrossRef
19.
go back to reference Steiner JF, Prochazka AV. The assessment of refill adherence using pharmacy records, methods, validity and application. J Clin Epidemiol. 1997;50(1):105–16.PubMedCrossRef Steiner JF, Prochazka AV. The assessment of refill adherence using pharmacy records, methods, validity and application. J Clin Epidemiol. 1997;50(1):105–16.PubMedCrossRef
Metadata
Title
Challenges in measuring medication adherence: experiences from a controlled trial
Authors
Kay Stewart
Kevin P. Mc Namara
Johnson George
Publication date
01-02-2014
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 1/2014
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-013-9877-6

Other articles of this Issue 1/2014

International Journal of Clinical Pharmacy 1/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.